Non-Small Cell Lung Cancer
Conditions
Interventions
None listed
Sponsors
Osaka Prefectural Hospital Organization Osaka Habikino Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Unresectable or progressive non-small cell lung Cancer patient treated with ICI alone regardless of the number of the previous regimens. 2.Twenty years old or older patient at registration. 3. Patients with performance status 0-2. 4. Patients with the measurable lesion. 5. Written Informed Consent from the patient
Exclusion criteria
Exclusion criteria: 1.Patient with an active heterochronous or synchronous overlap cancer (carcinoma-insitu or cured intramucosal canceris excluded from overlap cancer) 2 Patient with active liver disease (ex. HBV-DNA positive, autoimmune hepatitis, anliver cirrhosis). 3 Female patient with the possibility (intention) of the pregnancy. Patient whom the Doctor in charge judged to be inappropriate as an object of this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Association between IFN-gamm and efficacy, immune-related adverse events, or Hyper progressive Disease in Patients with Non-Small Cell Lung Cancer receiving ICI | — |
Countries
Japan
Contacts
Public ContactHidekazu Suzuki
Osaka Habikino Medical Center Thoracic Oncology
Outcome results
None listed